IRIS
GABRIELLI, Armando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.723
EU - Europa 10.291
AS - Asia 7.066
SA - Sud America 1.979
Continente sconosciuto - Info sul continente non disponibili 436
AF - Africa 395
OC - Oceania 9
AN - Antartide 1
Totale 36.900
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.383
RU - Federazione Russa 2.686
SG - Singapore 2.181
VN - Vietnam 1.625
BR - Brasile 1.530
IT - Italia 1.447
UA - Ucraina 1.376
CN - Cina 1.161
DE - Germania 955
SE - Svezia 919
IE - Irlanda 747
FR - Francia 567
HK - Hong Kong 521
TR - Turchia 514
DK - Danimarca 464
FI - Finlandia 426
GB - Regno Unito 321
KR - Corea 249
BD - Bangladesh 165
IN - India 165
CA - Canada 157
AR - Argentina 146
CI - Costa d'Avorio 130
MX - Messico 100
EC - Ecuador 96
PL - Polonia 93
MA - Marocco 91
IQ - Iraq 78
NL - Olanda 72
ZA - Sudafrica 69
ID - Indonesia 68
JP - Giappone 57
VE - Venezuela 54
CO - Colombia 53
PK - Pakistan 43
ES - Italia 41
BE - Belgio 38
AT - Austria 32
PY - Paraguay 28
CL - Cile 26
TN - Tunisia 26
UZ - Uzbekistan 26
PH - Filippine 24
SA - Arabia Saudita 23
EG - Egitto 19
UY - Uruguay 18
KE - Kenya 17
MY - Malesia 17
LT - Lituania 16
RS - Serbia 16
NP - Nepal 15
CR - Costa Rica 14
EU - Europa 14
JM - Giamaica 14
JO - Giordania 14
BO - Bolivia 13
AL - Albania 12
LB - Libano 12
OM - Oman 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
PE - Perù 11
ET - Etiopia 10
TH - Thailandia 10
DO - Repubblica Dominicana 9
KZ - Kazakistan 9
TW - Taiwan 9
IL - Israele 8
AU - Australia 7
AZ - Azerbaigian 7
IR - Iran 7
PS - Palestinian Territory 7
CH - Svizzera 6
HN - Honduras 6
HR - Croazia 6
NI - Nicaragua 6
SN - Senegal 6
TT - Trinidad e Tobago 6
BA - Bosnia-Erzegovina 5
CZ - Repubblica Ceca 5
GT - Guatemala 5
MD - Moldavia 5
PT - Portogallo 5
RO - Romania 5
SV - El Salvador 5
XK - ???statistics.table.value.countryCode.XK??? 5
BG - Bulgaria 4
CG - Congo 4
GE - Georgia 4
GR - Grecia 4
PA - Panama 4
BB - Barbados 3
BY - Bielorussia 3
EE - Estonia 3
GA - Gabon 3
KW - Kuwait 3
PR - Porto Rico 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
Totale 36.435
Salva come PNG Salva come JPEG
Città #
Ashburn 2.229
Chandler 1.449
Jacksonville 1.410
Singapore 1.330
Fairfield 836
Dublin 743
San Jose 724
Council Bluffs 710
Boardman 684
Dallas 676
Ho Chi Minh City 557
Wilmington 548
Hong Kong 503
New York 465
Woodbridge 393
Houston 373
Hanoi 362
Seattle 349
Beijing 343
Centro 323
The Dalles 313
Des Moines 311
Princeton 296
Lawrence 295
San Mateo 295
Lauterbourg 270
Los Angeles 267
Munich 257
Moscow 237
Cambridge 231
Ann Arbor 224
Hefei 160
Helsinki 150
São Paulo 142
Milan 141
Abidjan 129
San Diego 111
Buffalo 103
Chicago 87
Da Nang 86
Orem 80
Haiphong 73
London 71
Santa Clara 71
Turin 69
Warsaw 64
Ancona 54
Rio de Janeiro 51
Turku 48
Montreal 47
Pune 46
Denver 44
Chennai 43
Frankfurt am Main 42
Guangzhou 42
Tokyo 42
Rome 41
Brooklyn 40
Johannesburg 40
Phoenix 40
Miano 39
Washington 39
Boston 37
Nuremberg 37
Shanghai 37
Stockholm 37
Atlanta 35
Brussels 35
Marche 35
Redmond 35
Belo Horizonte 34
Porto Alegre 32
Quito 32
Mexico City 31
Brasília 30
Toronto 29
Baghdad 28
Curitiba 28
Norwalk 28
Guayaquil 27
Hải Dương 26
Poplar 26
Manchester 24
Amsterdam 23
Biên Hòa 23
Tashkent 23
Wuhan 23
Jesi 22
Porto 20
San Francisco 20
Ankara 19
Charlotte 19
Jiaxing 19
Thái Bình 19
Auburn Hills 18
Montevideo 18
Salt Lake City 18
Guarulhos 17
Izmir 17
Belgrade 16
Totale 21.235
Salva come PNG Salva come JPEG
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 845
ALTERATIONS OF ROS PATHWAYS IN SCLERODERMA BEGIN AT STEM CELL LEVEL 816
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 305
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 211
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 193
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 192
Diagnosis and management of leukocytoclastic vasculitis 186
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients 185
Metabolomic profile of systemic sclerosis patients 181
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 181
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 177
Adalimumab modulates angiogenesis in psoriatic skin 176
Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis 176
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. 175
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 174
Systemic sclerosis (scleroderma) and cancer risk: Systematic review and meta-analysis of observational studies 172
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 172
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 172
Successful treatment of a Caucasian case of multifocal Castleman¿s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report 170
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 170
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 170
c-MYB transactivates the alpha 2(I) collagen gene. 167
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 166
Abnormal cerebrovascular reactivity and cognitive impairment in systemic sclerosis 165
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 161
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 161
A randomized controlled trial of Rituximab for the treatment of severe cryoglobulinemic vasculitis. 160
Cardiac involvement in polymyositis and dermatomyositis 160
La terapia con immunoglobuline endovena nelle malattie autoimmuni 156
Activation in vitro of scleroderma skin fibroblasts is sustained by increased generation of free radicals through the NADPH-oxidase pathway. 156
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 156
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 156
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 155
Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality 155
Cognitive and cerebral hemodynamic impairment in scleroderma patients 154
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 154
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 153
Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange 153
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. 153
Computed tomography assessment of evolution of interstitial lung disease in systemic sclerosis: Comparison of two scoring systems 152
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 152
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 151
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 151
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 150
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 150
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 150
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 150
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 149
Acute myocarditis associated with adenoviral infection in a patient with scleroderma 148
c-myb but not B-myb upregulates a1(I) and a2(I) collagen genes in fibroblasts 146
A novel HLA-Cw*6 allele Cw*160102, identified by cloning and sequencing. 146
Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry 146
Subcutaneous IgG in the Myositis Spectrum Disorders 145
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 145
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 145
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 144
c-myb proto-oncogene is expressed by quiescent fibroblasts and unlike B-myb gene does not correlate with proliferation 143
Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein. 143
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 143
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database 141
Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. 141
Certolizumab pegol for the treatment of psoriasis 141
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 140
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 140
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 139
Mapping and predicting mortality from systemic sclerosis 139
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. 138
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. 138
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 138
Piascledine modullates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes 137
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study 137
Comparsa di polmonite in soggetto con storia recente di inappetenza, disfagia, calo ponderale, ed eritema diffuso. 137
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 136
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 136
Assessment of gastrointestinal involvement in scleroderma. 135
AIRE gene polymorphisms in Systemic Sclerosis associated with autoimmune thyroiditis 135
Traiano: Educational (but not only) opportunity for Master Students 135
BIOLOGIC THERAPY IN INFLAMMATORY AND IMMUNOMEDIATED ARTHRITIS: SAFETY PROFILE 135
Digital ulcers predict a worse disease course in patients with systemic sclerosis 135
A painful diagnosis 135
Subclinical progression of systemic sclerosis-related cardiomyopathy 134
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 134
Biologics in inflammatory immune-mediated systemic diseases 134
Videofluorography swallow study in patients with systemic sclerosis: correlation with clinical and radiological features 134
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 133
Agonistic antibodies in systemic sclerosis 133
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 132
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 132
TOSSE STIZZOSA: PRESENTAZIONE ATIPICA DI UNA VASCULITE DEI GRANDI VASI 132
Update of EULAR recommendations for the treatment of systemic sclerosis 132
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 132
A novel iloprost administration method with portable syringe pump for the treatment of acral ulcers and Raynaud's phenomenon in systemic sclerosis patients. A pilot study (ILOPORTA). 132
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis 131
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 130
The long pentraxin PTX3 is a marker of scleroderma fibroblasts activation 129
Dr. Guerra, et al reply 129
Identification of a novel human DRB1*13 allele by sequence-based DRB typing. 128
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 128
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 127
Stimulatory autoantibodies against PDGF receptors in Scleroderma 127
Totale 16.500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.075
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.454 0 0 62 131 17 106 77 159 126 129 201 446
2022/20234.169 380 433 343 353 306 688 13 279 1.009 38 218 109
2023/20242.235 419 47 135 345 350 487 37 56 13 68 21 257
2024/20254.554 425 425 197 43 205 118 481 163 1.051 329 477 640
2025/202613.841 914 1.088 721 1.498 1.299 887 2.039 1.285 2.257 897 334 622
2026/20271.336 501 488 347 0 0 0 0 0 0 0 0 0
Totale 36.900